Bristol-Myers Squibb Looks to Continue to Trade Above its Annual-High Share ... Financial News Network Online The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. In the past 52 weeks, Bristol-Myers Squibb share prices have ... |
